Healthcare Utilization Based News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody.

San diegoUnited statesNavjot raiKathleen gallagherAvidity biosciences incDevelopment for the treatmentAvidity biosciencesAntibody oligonucleotide conjugatesScientific conferenceTrial evaluatingMyotonic dystrophy typeComorbid conditionsHealthcare utilization basedYear comparative real world dataNovel therapeutic approachDuchenne muscular dystrophy